DD
Highly rated in
60
conditions

Dr. Donald C. Doll

Cardiology Clinic
Columbia, MO
Highly rated in
60
conditions
Specialties:Hematology Oncology
Experience:51 Years
Accepts:New PatientsMedicare
Highly rated in
60
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Donald C. Doll's experience treating your condition:
About Dr. Donald C. Doll

Donald Doll is a Hematologist Oncology expert in Columbia, Missouri. Doll has been practicing medicine for over 51 years and is highly rated in 60 conditions, according to our data. His top areas of expertise are Autoimmune Hemolytic Anemia, Glioma, Brain Tumor, Glioblastoma, and Bone Marrow Aspiration. He is licensed to treat patients in Missouri. Doll is currently accepting new patients.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Donald C. Doll it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Donald C. Doll accepts the following insurance:

  •  Medica
  •  Health Alliance
Call to see if your plan is accepted.
Locations
1 Hospital Dr, Columbia, MO 65212
Background & Education
Graduate Institution
University Of Iowa, Rj & L Carver College Of Medicine, 1972
Specialties
Hematology Oncology
Licenses
Internal Medicine in MO
Hospital Affiliations
University Hospital
Ellis Fischel Cancer Center
Audrain Community Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
Enrollment Status: Suspended
Publish Date: December 13, 2022
Intervention Type: Drug, Biological
Study Drugs: CyclophosphamideDoxorubicin HydrochlorideEtoposidePrednisoneRituximabVenetoclaxVincristine Sulfate
Study Phase: Phase 2/Phase 3
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active, not recruiting
Publish Date: December 12, 2022
Intervention Type: Drug, Other
Study Drugs: AnastrozoleExemestaneLetrozoleSystemic Chemotherapy
Study Phase: Phase 3
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active, not recruiting
Publish Date: December 12, 2022
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: IbrutinibObinutuzumabVenetoclax
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active, not recruiting
Publish Date: October 27, 2022
Intervention Type: Radiation, Biological
Study Drug: Cetuximab
Study Phase: Phase 3
Intergroup Randomized Phase 2 Four Arm Study In Patients ≥ 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR)
Enrollment Status: Active, not recruiting
Publish Date: August 12, 2022
Intervention Type: Drug, Biological
Study Drugs: RituximabBendamustine HydrochlorideBortezomibLenalidomide
Study Phase: Phase 2
View 4 Less Clinical Trials -
20 Total Publications
A Rare Case of Glioblastoma With Extensive Liver Metastases.
Journal: Oncology (Williston Park, N.Y.)
Published: January 28, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
EB
Dr. Elangovan Balakrishnan
Hematology Oncology | Oncology | Hematology
Highly rated in
43
conditions
Hematology Oncology
Oncology
Hematology

Missouri Cancer Associates - Columbia

Columbia, MO 
 1.1 mi

Elangovan Balakrishnan is a Hematologist Oncology specialist and an Oncologist in Columbia, Missouri. Balakrishnan has been practicing medicine for over 30 years and is highly rated in 43 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Leiomyosarcoma, Bone Marrow Aspiration, and Endoscopy. He is licensed to treat patients in Missouri. Balakrishnan is currently accepting new patients.

MT
Mark M. Tungesvik
Dr. Mark M. Tungesvik
Hematology Oncology | Hematology | Oncology
Highly rated in
20
conditions
Hematology Oncology
Hematology
Oncology

Missouri Cancer Associates

Columbia, MO 
 1.1 mi

Mark Tungesvik is a Hematologist Oncology specialist and a Hematologist in Columbia, Missouri. Tungesvik has been practicing medicine for over 22 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, Bone Marrow Aspiration, and Endoscopy. He is licensed to treat patients in Missouri. Tungesvik is currently accepting new patients.

LM
Liana Makarian
Dr. Liana Makarian
Hematology Oncology | Oncology
Highly rated in
23
conditions
Hematology Oncology
Oncology

Missouri Cancer Associates

Columbia, MO 
 1.1 mi

Liana Makarian is a Hematologist Oncology specialist and an Oncologist in Columbia, Missouri. Makarian has been practicing medicine for over 18 years and is highly rated in 23 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, Colorectal Cancer, Breast Cancer, Bone Marrow Aspiration, and Endoscopy. She is licensed to treat patients in Missouri. Makarian is currently accepting new patients.